[Difficult therapy in patients with renal failure. What protects, what damages the kidneys?].
Stiefelhagen
Peter
P
D000959:Antihypertensive Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003928:Diabetic Nephropathies / Q000097:blood / Q000188:drug therapy / Q000209:etiology; D004039:Diet, Sodium-Restricted; D004044:Dietary Proteins / Q000008:administration & dosage; D006801:Humans; D006977:Hypertension, Renal / Q000097:blood / Q000188:drug therapy / Q000209:etiology; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D007328:Insulin / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D011507:Proteinuria / Q000097:blood / Q000188:drug therapy / Q000209:etiology; D012076:Renal Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006435:Renal Dialysis; D016540:Smoking Cessation
D000959:Antihypertensive Agents; D004044:Dietary Proteins; D007004:Hypoglycemic Agents; D007328:Insulin; D012076:Renal Agents